3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma, Ewing
3
Sarcoma
2
Osteosarcoma
2
Lymphoma, Large B-Cell, Diffuse
2
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Malignant mesenchymal tumor
1
Lymphoma, Follicular
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Fibrosarcoma
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Interventions
Cyclophosphamide
13
Rituximab
11
obinutuzumab
6
fludarabine phosphate
6
Prednisone
6
Magnetic Resonance Spectroscopy
6
ibrutinib
5
fludarabine
5
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Lenalidomide
5
Etoposide
5
Doxorubicin
5
Biopsy
5
tocilizumab
4
Whole-Body Irradiation
4
venetoclax
3
polatuzumab vedotin
3
glofitamab
3
acalabrutinib
3
Vincristine
3
Mycophenolic Acid
3
Leukapheresis
3
Filgrastim
3
Cytarabine
3
Cyclosporine
3
Busulfan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
Ifosfamide
×
30 days
×
Clear all
No trials found.